End-Stage Liver Disease
What liver failure means, the warning signs, how MELD measures it, and when to ask about a transplant.
What liver failure means, the warning signs, how MELD measures it, and when to ask about a transplant.
End-stage liver disease (ESLD) is the point where the liver is so badly damaged that it can no longer do its job. Doctors also call it liver failure. The National Institutes of Health explains it simply: liver failure, also called end-stage liver disease, happens when the liver stops working, and the only treatment for it is a liver transplant.
Most people reach this stage slowly, over years, after a long-term liver disease causes scarring called cirrhosis. Common causes include alcohol-associated liver disease, fatty liver disease, and long-term hepatitis B or C. Less common causes include autoimmune hepatitis, bile duct diseases, and inherited conditions such as Wilson disease.
ESLD is serious, but it is not a moment to give up. It is the moment to make sure you have a hepatologist (liver specialist), a plan for the symptoms, and a clear answer about whether you should be evaluated for a place on the liver transplant waiting list.
The words are related, but they are not the same thing. Cirrhosis means the liver is scarred and permanently damaged. Scar tissue replaces healthy tissue and partly blocks blood flow through the liver. Many people with cirrhosis feel fine for years.
Doctors split cirrhosis into two phases. In compensated cirrhosis, the liver is scarred but still keeps up. In decompensated cirrhosis, a major complication has appeared, such as fluid in the belly (ascites), bleeding from swollen veins, confusion from toxins (hepatic encephalopathy), a belly infection, or kidney failure. When people say "end-stage liver disease," they usually mean decompensated cirrhosis or full liver failure. You can see how these fit together on our stages of liver disease page.
| Stage | What is happening | What it often feels like |
|---|---|---|
| Compensated cirrhosis | Liver is scarred but still working well enough | Often no symptoms, or tiredness, itching, poor appetite |
| Decompensated cirrhosis | At least one major complication has appeared | Belly swelling, confusion, bleeding, yellow skin or eyes |
| End-stage liver disease / liver failure | Liver can no longer do its work; complications keep coming back | Frequent hospital stays; symptoms are hard to control |
Early cirrhosis may cause no symptoms at all. As liver function gets worse, the NIH lists these signs to watch for:
Vomiting blood or black or bloody stools can be signs of internal bleeding, which is a medical emergency. New confusion, a fever, or a painful, swollen belly can be signs of hepatic encephalopathy or infection.
Most of the dangers of ESLD come from portal hypertension, which is high blood pressure in the large vein that carries blood into the liver. Scar tissue slows blood flow, pressure builds, and problems show up in other parts of the body.
Fluid collects in the abdomen and can make it hard to eat or breathe. Doctors treat it with water pills, a low-sodium diet, and sometimes by draining the fluid with a needle. Ascites can become infected, a condition called spontaneous bacterial peritonitis, which needs antibiotics.
When the liver cannot clear toxins, they build up in the brain. This can cause confusion, trouble thinking, memory loss, personality changes, or sleep problems. Medicines can lower the toxin levels and help thinking improve.
Swollen veins called varices form in the esophagus or stomach. If they burst, bleeding can be severe. Medicines lower the pressure in these veins, and doctors can treat or prevent bleeding during an upper endoscopy.
Yellow skin and eyes happen when the liver cannot clear bilirubin, a waste product from old red blood cells. Rising bilirubin is one of the numbers that raises a MELD score.
Advanced liver disease can cause the kidneys to fail even though the kidneys themselves are not diseased. This is called hepatorenal syndrome. It is one of the complications that defines decompensated cirrhosis, and the University of Washington's clinical guide says people who develop it should be urgently referred to a transplant center.
Cirrhosis raises the chance of bacterial infections such as pneumonia and urinary tract infections. It also raises the risk of liver cancer, which is why doctors often check with an ultrasound and blood tests every 6 months.
The MELD score (Model for End-Stage Liver Disease) is the number U.S. transplant programs use to rank how sick an adult is. It runs from 6 to 40. A higher score means a higher estimated risk of dying in the next 90 days without a transplant, and a higher place in line for a donor liver.
Since July 2023, the national transplant system has used MELD 3.0. It is calculated from routine blood tests plus one other factor:
| MELD 3.0 input | What it tells your team |
|---|---|
| Bilirubin | How well the liver clears waste (jaundice) |
| INR | How well the liver makes clotting proteins |
| Creatinine | How well the kidneys are working |
| Sodium | Low blood sodium adds to the risk estimate |
| Albumin | A protein the liver makes; low levels signal a weaker liver |
| Sex | Added so women are not under-scored compared with men |
When researchers built MELD 3.0, it predicted 90-day survival slightly better than the older MELD-Na score and moved more of the sickest patients, especially women, into higher priority groups. You can estimate your own number with our MELD calculator, but your transplant team's official score is the one that counts.
MELD is useful, but it does not capture everything. Some people with low scores still have hard-to-control ascites, repeated confusion, or poor quality of life. Tell your hepatologist about symptoms, not just lab numbers.
This is often the hardest question families ask. There is no single answer, because survival depends on the cause of the liver disease, which complications have appeared, the MELD score, other health problems, and whether a transplant happens. What the research does show is that the first major complication is a turning point:
A liver transplant changes that outlook. In the United States, about 92% of liver transplant recipients are alive 1 year after surgery and about 76% at 5 years. These are averages for groups of people, not a prediction for any one person. Ask your hepatologist what your own numbers mean.
National guidance from the AASLD and the American Society of Transplantation says a person with cirrhosis should be referred to a transplant center when either of these happens:
Liver cancer that fits transplant size limits is another reason to be referred. Kidney failure from liver disease, or any fast decline, calls for urgent referral.
Do not wait until you feel very sick. A transplant evaluation can take weeks to months, and a delayed referral leaves less time to finish testing and get listed. If your doctor has not raised it, you can ask directly: "Have I met the criteria for a transplant referral?" Our guide to who qualifies for a liver transplant walks through the evaluation step by step, and our list of liver transplant centers can help you find a program.
Doctors cannot reverse cirrhosis, but treating the cause and the complications can slow damage and ease symptoms. That can include stopping alcohol completely, treating hepatitis, managing fluid and confusion, and checking with your doctor before taking any medicine or supplement, including over-the-counter pain relievers.
Palliative care is extra support focused on comfort, symptoms, and quality of life for both the patient and the family. The AASLD says palliative care can be given at any stage of decompensated cirrhosis, and that being evaluated or listed for a transplant does not rule it out. It is not the same as hospice. Hospice is comfort-only care for people whose life expectancy is measured in months.
Caregivers carry a heavy load, too. The same guidance calls caring for caregivers a central part of good care. If you are supporting someone with ESLD, our support page is a place to start.
Cirrhosis is scarring of the liver. Many people with cirrhosis feel well for years. End-stage liver disease is the later point where the scarred liver can no longer keep up and major complications, such as ascites, confusion, or bleeding, appear. See our stages of liver disease page.
Warning signs include a growing belly from fluid, new or worse confusion or sleepiness, yellowing skin or eyes, easy bruising, swelling in the legs, and vomiting blood or passing black stools. Vomiting blood or black stools needs emergency care. Tell your hepatologist about any new symptom, even if your labs look stable.
It varies a great deal from person to person. In one long-term study, about half of people were alive 5 years after their first major complication, and about 1 in 5 died within the first year. A liver transplant changes the outlook: about 92% of U.S. recipients are alive 1 year after surgery. Ask your hepatologist what your own situation means.
There is no single cutoff. MELD runs from 6 to 40, and higher scores mean a higher risk of dying within 90 days without a transplant. National guidance says people with cirrhosis should be referred for a transplant evaluation at a MELD score of 15 or higher, or after their first major complication, whichever comes first.
ESLD is serious, and a liver transplant is the only treatment that replaces a failed liver. Treating the cause, such as stopping alcohol or treating hepatitis, and managing complications can slow the disease and improve symptoms for some people. Your hepatologist can tell you what is possible in your case.
Yes. The American Association for the Study of Liver Diseases says palliative care can be given at any stage of decompensated cirrhosis, including during transplant evaluation and listing. Palliative care focuses on symptoms and quality of life. It is different from hospice, which is comfort-only care.
Ask when you have your first major complication (ascites, variceal bleeding, or hepatic encephalopathy) or when your MELD score reaches 15. Kidney problems or a fast decline call for urgent referral. Our guide to who qualifies for a liver transplant explains the next steps.
Medically reviewed by James F. Trotter, MD and Joseph S. Redman, MD, PhD of the National Friends Medical Advisory Board on . Reviewers check clinical statements against the cited sources; data tables come from the public SRTR program-specific reports and OPTN policy.
Published by Friends of the National Liver Waiting List, a 501(c)(3) patient advocacy charity. Updated . Not medical advice: talk with your hepatologist or transplant team about your own care.